Exact Sciences Corp - Nilai perusahaan marang pendapatan EXAS

exactsciences.com (EXAS) - logo korporat

Despite pressure in the liquid biopsy sector, Exact Sciences attracts leading geneticists due to its strong ethics and R&D investments. The enterprise value-to-revenue multiple helps value the asset regardless of debt, while 6651.19 represents the latest level. Diagnostic efficiency is maintained through external logistics and the outsourcing of IT platforms.

EXAS (Exact Sciences Inc.) riwayat Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 04.04.2026

Exact Sciences Inc. - rincian analitis lan metrik utama (EXAS)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental perusahaan:EXAS (Exact Sciences)
Produk asli Cologuard

The selection of high-quality issuers is based on an analysis of multiples that exclude the impact of debt structure on market value. The EV/Sales metric measures the total enterprise value relative to revenue, allowing for an assessment of revenue generation efficiency regardless of leverage. For Exact Sciences (EXAS), whose growth is driven by innovation and inelastic demand, changes in the EV/Sales valuation confirm the fundamental resilience of the business across economic cycles.

Analisis pesaing Exact Sciences

A (Agilent) - Rasio nilai perusahaan marang pendapatan|DGX (Quest Diagnostics) - Nilai perusahaan marang pendapatan|Illumina Inc (ILMN) - Multiplikator EV/Sales|RVTY (Revvity Corp) - Multiplikator EV/Sales|Multiplikator EV/Sales Bio-Rad Laboratories Inc|Nilai perusahaan marang pendapatan NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan QuidelOrtho Inc. QDEL|Multiplikator EV/Sales OPKO Health Inc OPK|CareDx Inc - Multiplikator EV/Sales|Nilai bisnis marang pendapatan MRVI (Maravai)|FLGT: Multiplikator EV/Sales|LAB (Standard BioTools Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Cytek Biosciences Inc|Multiplikator nilai perusahaan marang pendapatan OraSure OSUR|Nilai perusahaan marang pendapatan XGN (Exagen Diagnostics)|Rasio total nilai perusahaan marang pendapatan MDxHealth Inc.|Rasio nilai perusahaan marang pendapatan Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Multiplikator nilai perusahaan marang pendapatan|Insight Molecular Diagnostics Inc - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan trinitybiotech.com|PRPH (ProPhase) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AIMD|Nilai perusahaan marang pendapatan CODX|Multiplikator nilai perusahaan marang pendapatan heartsciences.com HSCS|Rasio nilai perusahaan marang pendapatan Biomerica Inc. (BMRA)|Rasio total nilai perusahaan marang pendapatan Cardio Diagnostics Holdings|Multiplikator EV/Sales ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Multiplikator nilai perusahaan marang pendapatan|bluejaydx.com - Multiplikator EV/Sales|Aspira Women's Health - Koefisien nilai perusahaan marang pendapatan|AXDX (Accelerate Diagnostics) - Nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan CENTOGENE, N.V.|Rasio nilai perusahaan marang pendapatan enzo.com|Multiplikator EV/Sales Fresh2 Group Limited|Multiplikator EV/Sales GENE|23andMe Holding Co. - Rasio nilai perusahaan marang pendapatan|Psychemedics Inc - Nilai perusahaan marang pendapatan